Advertisement
U.S. markets closed

CompuGroup Medical SE & Co. KGaA (CMPVF)

Other OTC - Other OTC Delayed Price. Currency in USD
29.890.00 (0.00%)
At close: 03:29PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
1.60B2.05B2.56B2.66B2.00B
Enterprise Value
2.35B2.78B3.26B3.42B2.76B
Trailing P/E
19.1622.69N/AN/A23.28
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.191.67N/AN/A1.53
Price/Book (mrq)
2.062.98N/AN/A2.46
Enterprise Value/Revenue
1.959.7110.7111.758.43
Enterprise Value/EBITDA
9.7246.6241.7565.2153.30

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3-12.09%
S&P500 52-Week Change 327.86%
52 Week High 340.75
52 Week Low 329.89
50-Day Moving Average 335.91
200-Day Moving Average 336.42

Share Statistics

Avg Vol (3 month) 33
Avg Vol (10 day) 310
Shares Outstanding 552.23M
Implied Shares Outstanding 653.64M
Float 825.14M
% Held by Insiders 150.34%
% Held by Institutions 128.79%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.54
Forward Annual Dividend Yield 41.81%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 434.72%
Dividend Date 3N/A
Ex-Dividend Date 4May 18, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 3.74%
Operating Margin (ttm)-0.66%

Management Effectiveness

Return on Assets (ttm)3.68%
Return on Equity (ttm)6.98%

Income Statement

Revenue (ttm)1.23B
Revenue Per Share (ttm)23.50
Quarterly Revenue Growth (yoy)-5.70%
Gross Profit (ttm)N/A
EBITDA 229.2M
Net Income Avi to Common (ttm)45.92M
Diluted EPS (ttm)1.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.46M
Total Cash Per Share (mrq)1.23
Total Debt (mrq)766.94M
Total Debt/Equity (mrq)114.59%
Current Ratio (mrq)1.09
Book Value Per Share (mrq)12.78

Cash Flow Statement

Operating Cash Flow (ttm)179.53M
Levered Free Cash Flow (ttm)111.37M